MedPath

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)

Phase 3
Terminated
Conditions
Type 1 Diabetes Mellitus
Interventions
Drug: Placebo
Registration Number
NCT00723411
Lead Sponsor
Diamyd Therapeutics AB
Brief Summary

The purpose of this study is to determine whether Diamyd (rhGAD65 formulated in alum) is effective in preserving the body's own insulin producing capacity in patients recently diagnosed with type 1 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
334
Inclusion Criteria
  • Male and female patients between 10 and 20 years of age
  • Insulin dependent type 1 diabetes mellitus diagnosed within the previous 3 months at time of screening
  • Fasting C-peptide level at time of screening above 0.1 nmol/L
  • Elevated GAD65 antibodies (GADA) at time of screening

Main

Exclusion Criteria
  • Treatment with immunosuppressants or any anti-diabetic medications other than insulin
  • A history of certain diseases or conditions (e.g. anemia, HIV, hepatitis, epilepsy, head trauma, neurological diseases or cerebrovascular accident, alcohol or drug abuse etc)
  • Treatment with any vaccine within 1 month prior to planned first Diamyd dose or planned treatment with vaccine up to 2 months after the last injection with Diamyd, excluding the influenza vaccine
  • Participation in other clinical trials with a new chemical entity within the previous 3 months
  • Pregnancy or planned pregnancy within 1 year after the last Diamyd dose
  • Presence of associated serious disease or condition which in the opinion of the investigator makes the patient non-eligible for the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CPlaceboThis arm will receive 4 injections of placebo, 1 each on Days 1, 30, 90, and 270.
ArhGAD65This arm will receive 2 subcutaneous injections with 20 µg Diamyd on Days 1 and 30, i.e., 1 prime and 1 booster dose, followed by 2 additional single doses with Diamyd 20 µg on Days 90 and 270.
BrhGAD65This arm will receive 2 subcutaneous injections with 20 µg Diamyd on Days 1 and 30, i.e., 1 prime and 1 booster dose, followed by 2 additional single doses with placebo on Days 90 and 270.
Primary Outcome Measures
NameTimeMethod
Meal stimulated C-peptide (area under the curve)15 months
Secondary Outcome Measures
NameTimeMethod
HbA1c15 months
Insulin Dose15 months

Trial Locations

Locations (65)

Seinäjoen keskussairaala, Lastentautien poliklinikka

🇫🇮

Seinäjoki, Finland

Orbis Medisch Centrum

🇳🇱

Sittard-Geleen, Netherlands

Turun yliopistollinen keskussairaala, Lastentautien Klinikka

🇫🇮

Turku, Finland

Kuopion yliopistollinen sairaala, Lasten klinikka

🇫🇮

Kuopio, Finland

Diabeter

🇳🇱

Rotterdam, Netherlands

Helsingin yliopistollinen keskussairaala, Lasten ja nuorten sairaala

🇫🇮

Helsinki, Finland

University Medical Centre Ljubljana, Department of Pediatric Endocrinology

🇸🇮

Ljubljana, Slovenia

Meander Medisch Centrum, Lokatie Elisabeth

🇳🇱

Amersfoort, Netherlands

CHU Timone Enfants, Service de pédiatrie multidisciplinaire

🇫🇷

Marseilles, France

Hôpital Jeanne de Flandre Sce Pédiatrie

🇫🇷

Lille, France

C.H.U.Serv.Pediatrie

🇫🇷

Nantes, France

Hôpital Necker, Clinique Robert Debré, Diabète de l'Enfant et de l'Adolescent,

🇫🇷

Paris, France

CHU Rennes

🇫🇷

Rennes, France

Tampereen yliopistollinen sairaala, Lasten klinikka

🇫🇮

Tampere, Finland

Hôpital Pellegrin Enfants, Service d'endocrinologie pédiatrique

🇫🇷

Bordeaux, France

CHU Montpellier Hôpital Arnaud de Villeneuve, Service de Pédiatrie 1

🇫🇷

Montpellier, France

Hannover Kinderkrankenhaus auf der Bult

🇩🇪

Hannover, Germany

KHK Wilhelmstift

🇩🇪

Hamburg-Rahlstedt, Germany

Hopital Robert Debré, Service d'Endocrinologie

🇫🇷

Paris, France

Klinik fȕr Kinder- und Jugendmedizin

🇩🇪

Mȕnchen, Germany

DRK Kliniken Westend

🇩🇪

Berlin, Germany

Charité Campus Virchow Childrens Hospital

🇩🇪

Berlin, Germany

Klinik und Poliklinik fȕr Kinder und Jugendliche der Universität Leipzig

🇩🇪

Leipzig, Germany

Hôpital des Enfants, Gastroentero-nutrition-diabétologie pédiatrique

🇫🇷

Toulouse, France

Universitätsklinik fȕr Kinder- und Jugendmedizin, Tȕbingen

🇩🇪

Tȕbingen, Germany

Unità Operativa di Pediatria, Policlinico

🇮🇹

Bologna, Italy

Reparto di Pediatria, Ospedale S. Raffaele

🇮🇹

Milano, Italy

Struttura Complessa di Diabetologia, Ospedale S. Michele

🇮🇹

Cagliari, Italy

S.S. Annunziata, Clinica Pediatrica

🇮🇹

Chieti, Italy

Clinica Pediatrica, Università di Genova

🇮🇹

Genova, Italy

Haga Ziekenhuis, Lokatie Juliana Kinderziekenhuis

🇳🇱

Den Haag, Netherlands

Diabetologia - Dipartimento Scienze Pediatriche, Ospedale Infantile, Regina Margherita

🇮🇹

Torino, Italy

Diabetologia - Dipartimento Clinica Pediatrica, Ospedale Luigi Sacco

🇮🇹

Milano, Italy

Azienda Ospedaliero, Universitaria di Parma, Pediatria

🇮🇹

Parma, Italy

Campus Bio-Medico, Dipartimento di Diabetologia e Endocrinologia

🇮🇹

Roma, Italy

Hospital Materno-Infantil de Cruces

🇪🇸

Cruces / Barakaldo, Spain

Hospital Materno-Infantil Vall Hebrón

🇪🇸

Barcelona, Spain

Hospital Materno-Infantil Ramón y Cajal

🇪🇸

Madrid, Spain

Barn- och ungdomskliniken, Länssjukhuset Ryhov

🇸🇪

Jönköping, Sweden

Barn- och ungdomskliniken, Centralsjukhuset

🇸🇪

Karlstad, Sweden

Barn- och ungdomskliniken, Universitetssjukhuset

🇸🇪

Örebro, Sweden

Hospital Materno-Infantil La Paz

🇪🇸

Madrid, Spain

Hospital Materno-Infantil Vírgen del Rocío

🇪🇸

Sevilla, Spain

Hospital Materno-Infantil Vírgen del Camino

🇪🇸

Pamplona, Spain

Hospital Materno-Infantil Carlos Haya

🇪🇸

Málaga, Spain

Barnkliniken, Hudiksvalls Sjukhus

🇸🇪

Hudiksvall, Sweden

Barn och ungdomsmedicinska kliniken, Centralsjukhuset

🇸🇪

Kristianstad, Sweden

Barn- och ungdomscentrum, Universitetssjukhuset MAS

🇸🇪

Malmö, Sweden

Hospital Materno-Infantil Clínico de Valencia

🇪🇸

Valencia, Spain

Hospital Materno-Infantil Miguel Servet

🇪🇸

Zaragoza, Spain

Barn- och ungdomskliniken, Lasarettet

🇸🇪

Kalmar, Sweden

Barn- och ungdomskliniken, Länssjukhuset

🇸🇪

Halmstad, Sweden

Drottning Silvias Barnsjukhus, Barn- och ungdomssjukvården

🇸🇪

Göteborg, Sweden

Barn- och ungdomsmedicin, Lasarettet

🇸🇪

Helsingborg, Sweden

Barn- och ungdomskliniken, Vrinnevi sjukhus

🇸🇪

Norrköping, Sweden

Sachsska Barnsjukhuset, Södersjukhuset

🇸🇪

Stockholm, Sweden

Barn- och ungdomskliniken, NU-sjukvården/NÄL

🇸🇪

Trollhättan, Sweden

Centre for Diabetes and Metabolic Medicine (DMM), Barts and The London School of Medicine and Dentistry

🇬🇧

London, United Kingdom

Children's Admin Centre

🇬🇧

Leicester, United Kingdom

Oulun yliopistollinen sairaala, Lasten ja nuorten klinikka

🇫🇮

Oulu, Finland

Medecine B

🇫🇷

Angers, France

Centre Hospitalier Universitaire de Besançon

🇫🇷

Besançon, France

Barn- och ungdomskliniken, Uddevalla Sjukhus

🇸🇪

Uddevalla, Sweden

Maternal & Child Health Sciences, University of Dundee

🇬🇧

Dundee, United Kingdom

Barn- och ungdomskliniken, Centrallasarettet

🇸🇪

Växjö, Sweden

© Copyright 2025. All Rights Reserved by MedPath